We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pathologists Collaborate to Improve Reporting and Accessibility of Cancer Pathology Findings

By LabMedica International staff writers
Posted on 28 Oct 2013
A new partnership has been formed to provide an electronic application service to enhance cancer pathology reporting and use of datasets.

The College of American Pathologists (CAP; Northfield, IL, USA) and mTuitive, Inc. More...
(Centerville, MA, USA) have forged a collaboration to more effectively capture and report cancer pathology findings by providing a product and service that will facilitate production and use of standardized, encoded, and interoperable data sets for use in patient care, registries, research, and biorepositories.

Together, the CAP and mTuitive have developed “CAP eFRM” – the CAP electronic Forms and Reporting Module, an application incorporating the CAP electronic Cancer Checklists (eCC). Cancer case summaries within 65 cancer protocols are electronically represented within the eCC in addition to two new tumor biomarker reporting templates for colon and lung cancer. eFRM was now presented at the CAP’s annual meeting (CAP 2013, Orlando, FA, USA). “We designed eFRM to help pathologists and laboratories make more effective use of data electronically as they care for patients,” said Charles Roussel, CAP CEO; “This application eases eCC implementation for health care and laboratory system vendors, ultimately benefiting pathologists, laboratory professionals, clinicians, and patients.”

The American College of Surgeons - Commission on Cancer (CoC) has also recognized the value of the CAP cancer protocols and has mandated that pathologists at CoC-approved cancer programs include the required data elements of the cancer protocols in their surgical pathology reports on cancer specimens.

mTuitive's unique method of capturing and reporting structured information provides valuable data for pathology, surgery, oncology, and cancer staging applications. “We believe in and are committed to what the CAP is doing in cancer care and, through our collaboration, eFRM furthers how information technology can improve care for cancer patients,” said John Murphy, CEO, mTuitive.

The CAP and mTuitive will offer two versions of eFRM. The first is a basic, standalone version; the second includes a wider range of functionality and was designed to be integrated within a laboratory information system. Both versions will facilitate broader adoption among pathologists and help simplify the management of content changes to the cancer protocols.

Related Links:

College of American Pathologists (CAP)
mTuitive



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
New
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.